A comparative study of functioning and non-functioning pituitary adenomas
- PMID: 33832102
- PMCID: PMC8036017
- DOI: 10.1097/MD.0000000000025306
A comparative study of functioning and non-functioning pituitary adenomas
Abstract
Pituitary tumors commonly cause visual impairment and the degree of impairment can depend on the size, location, and type of the tumor. However, no studies have been made regarding the differences caused by functioning pituitary adenoma (FPA) and non-functioning pituitary adenoma (NFPA). We aimed to investigate the relationship between clinical characteristics and visual impairment in patients with FPA and NFPA.This case series study included 73 pituitary adenoma patients. All patients underwent ophthalmic evaluations, and we retrospectively reviewed their medical records. Tumor types were confirmed by histological analysis, and the tumor volume was calculated. Magnetic resonance imaging was used to determine the tumor diameter. The observation indices of the two groups were compared. The correlation between the visual field and tumor volume was analysed using scatter plots.We enrolled 30 patients in the FPA group and 43 in the NFPA group. The first symptoms presented in the eyes in 23% of FPA patients and 41.9% of NFPA patients. The best-corrected visual acuity of the FPA group was better than that of the NFPA group, and 34 (56.7%) and 73 (84.9%) eyes in these groups had visual field defects, respectively. The visual field defects of the FPA patients were lighter than those of the NFPA patients. Except for the anteroposterior diameter, there were no differences in the other parameters of tumor diameter between the groups. The tumor volume of the FPA group was smaller than that of the NFPA group. The tumor size was positively correlated with the mean deviation and negatively correlated with the mean sensitivity in both groups.There was a longer delay between the onset of signs and symptoms and treatment in the FPA group than in the NFPA group. Future studies should focus on visual field defects caused by FPA and NFPA.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures


Similar articles
-
Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center.Pituitary. 2024 Oct;27(5):705-713. doi: 10.1007/s11102-024-01453-5. Epub 2024 Sep 13. Pituitary. 2024. PMID: 39269545
-
Clinical and prognostic implications of pituitary macroadenomas (PitNets) grading: a monocentric experience.Pituitary. 2025 Mar 13;28(2):41. doi: 10.1007/s11102-025-01508-1. Pituitary. 2025. PMID: 40082275
-
Relationship of each anterior pituitary hormone deficiency to the size of non-functioning pituitary adenoma in the hospitalized patients.Endocr J. 2016 Nov 30;63(11):965-976. doi: 10.1507/endocrj.EJ16-0168. Epub 2016 Aug 18. Endocr J. 2016. PMID: 27534814
-
Quality of care evaluation in non-functioning pituitary adenoma with chiasm compression: visual outcomes and timing of intervention clinical recommendations based on a systematic literature review and cohort study.Pituitary. 2020 Aug;23(4):417-429. doi: 10.1007/s11102-020-01044-0. Pituitary. 2020. PMID: 32419072 Free PMC article.
-
[Management of patients with non-functioning pituitary adenomas. Summary of results of an expert conference of the Hypophysis Work Group of the German Society of Endocrinology, Friedewald, 15-17 February 2002].Med Klin (Munich). 2003 Nov 15;98(11):616-27. doi: 10.1007/s00063-003-1307-4. Med Klin (Munich). 2003. PMID: 14631537 Review. German.
Cited by
-
Genome wide analysis of circulating miRNAs in growth hormone secreting pituitary neuroendocrine tumor patients' plasma.Front Oncol. 2022 Sep 9;12:894317. doi: 10.3389/fonc.2022.894317. eCollection 2022. Front Oncol. 2022. PMID: 36158656 Free PMC article.
-
Clinical presentation and recurrence of pituitary neuroendocrine tumors: results from a single referral center in Colombia.J Endocrinol Invest. 2023 Nov;46(11):2275-2286. doi: 10.1007/s40618-023-02080-w. Epub 2023 Mar 31. J Endocrinol Invest. 2023. PMID: 37002436
-
Multidisciplinary management of pituitary macroadenoma.World J Methodol. 2025 Sep 20;15(3):97694. doi: 10.5662/wjm.v15.i3.97694. eCollection 2025 Sep 20. World J Methodol. 2025. PMID: 40881218
-
Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center.Pituitary. 2024 Oct;27(5):705-713. doi: 10.1007/s11102-024-01453-5. Epub 2024 Sep 13. Pituitary. 2024. PMID: 39269545
-
Idiopathic and structural episodic nonintentional head tremor in dogs: 100 cases (2004-2022).J Vet Intern Med. 2023 Nov-Dec;37(6):2301-2309. doi: 10.1111/jvim.16880. Epub 2023 Oct 18. J Vet Intern Med. 2023. PMID: 37850712 Free PMC article.
References
-
- Bresson D, Herman P, Polivka M, et al. . Sellar lesions/pathology. Otolaryngol Clin North Am 2016;49:63–93. - PubMed
-
- Marazuela M, Astigarraga B, Vicente A, et al. . Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas. J Endocrinol Invest 1994;17:703–7. - PubMed
-
- Vié A-L, Raverot G. Modern neuro-ophthalmological evaluation of patients with pituitary disorders. Best Pract Res Clin Endocrinol Metab 2019;33:101279. - PubMed
-
- Levy MJ, Jäger HR, Powell M, et al. . Pituitary volume and headache: size is not everything. Arch Neurol 2004;61:721–5. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical